The Connection Between Mental Health and Weight Management

It’s the beginning of a new year, and messages about weight loss and self-improvement are everywhere—join a gym, try a new program, or start the latest medication. For some, these messages are about appearance or seasonal goals. For others, weight changes are far more complex and deeply intertwined with mental health, emotional well-being, and the treatments used to manage psychiatric conditions.

Mental Health, Medications, and Weight Changes

Mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia affect millions of people. While psychiatric medications can be life-changing and even lifesaving, many are associated with metabolic side effects, including weight gain. This is especially true for certain antidepressants, mood stabilizers, and antipsychotic medications.

Medication-related weight gain is not a cosmetic issue, it can significantly affect self-esteem, physical health, and treatment adherence. In fact, concerns about weight gain are among the most common reasons patients discontinue psychiatric medications or hesitate to start them, increasing the risk of symptom relapse and reduced quality of life.

Traditional Strategies for Managing Medication-Related Weight Gain

Historically, clinicians have relied on a limited set of tools to address psychotropic-induced weight gain. Medications such as metformin and topiramate have been used off-label to support weight management in psychiatric patients. While these options may offer modest benefit for some individuals, their effectiveness is often limited, and side effects...such as gastrointestinal discomfort or cognitive slowing, can restrict their use.

Lifestyle interventions, including nutrition counseling and physical activity, remain foundational but are not always sufficient when weight changes are driven by medication-related metabolic effects.

GLP-1 Medications: An Emerging Option

In recent years, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including semaglutide and tirzepatide, have emerged as promising tools for weight management. Originally developed for diabetes treatment, these medications have demonstrated significant benefits for weight loss and cardiometabolic health.

For individuals receiving psychiatric care, GLP-1 RAs may offer additional advantages. Research suggests these medications can help mitigate antipsychotic-associated weight gain and reduce cardiometabolic risk. Beyond metabolic effects, early and preclinical studies indicate potential benefits related to mood, anxiety, cognitive function, and even reductions in alcohol and substance use (De et al., 2023; Gunturu, 2024).

While these findings are still evolving, they highlight the possibility that GLP-1 medications may address both physical and mental health concerns simultaneously—an important consideration in whole-person psychiatric care.

A Whole-Person Approach to Mental and Physical Health

Weight management in mental health care should never be approached in isolation. Emotional well-being, medication effects, lifestyle factors, and physical health are deeply interconnected. For some individuals, newer treatment options like GLP-1 medications may provide meaningful support when weight gain becomes a barrier to effective psychiatric treatment.

Ongoing research will continue to clarify the role of GLP-1 RAs in mental health settings. In the meantime, thoughtful, individualized care—one that considers both mind and body—is essential to helping patients feel better, function better, and remain engaged in treatment.

What has your experience been with weight changes and mental health treatment?

Learn more about weight managment and GLP-1s roles in mental health

References

De, R., Prasad, F., Stogios, N., Burin, L., Ebdrup, B. H., Knop, F. K., … Agarwal, S. M. (2023). Promising translatable pharmacological interventions for body weight management in individuals with severe mental illness – a narrative review. Expert Opinion on Pharmacotherapy, 24(16), 1823–1832. https://doi.org/10.1080/14656566.2023.2254698

Gunturu S. The Potential Role of GLP-1 Agonists in Psychiatric Disorders: A Paradigm Shift in Mental Health Treatment. Indian Journal of Psychological Medicine. 2024;46(3):193-195. doi:10.1177/02537176241246744